NTV Asset Management LLC continued to hold its position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,878 shares of the pharmacy operator’s stock at the end of the second quarter. NTV Asset Management LLC’s holdings in CVS Health Corporation were worth $275,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Sentry Investments Corp. boosted its position in CVS Health Corporation by 6.3% in the first quarter. Sentry Investments Corp. now owns 2,179,600 shares of the pharmacy operator’s stock worth $226,090,000 after buying an additional 128,300 shares during the period. Lodestar Investment Counsel LLC IL boosted its position in CVS Health Corporation by 4.2% in the second quarter. Lodestar Investment Counsel LLC IL now owns 176,387 shares of the pharmacy operator’s stock worth $16,887,000 after buying an additional 7,136 shares during the period. Atwood & Palmer Inc. boosted its position in CVS Health Corporation by 1.5% in the second quarter. Atwood & Palmer Inc. now owns 202,127 shares of the pharmacy operator’s stock worth $19,352,000 after buying an additional 3,059 shares during the period. Scharf Investments LLC boosted its position in CVS Health Corporation by 4.2% in the first quarter. Scharf Investments LLC now owns 1,914,846 shares of the pharmacy operator’s stock worth $198,627,000 after buying an additional 76,797 shares during the period. Finally, Legal & General Group Plc boosted its stake in shares of CVS Health Corporation by 1.9% in the first quarter. Legal & General Group Plc now owns 4,961,136 shares of the pharmacy operator’s stock worth $514,632,000 after buying an additional 92,196 shares during the last quarter. 81.08% of the stock is currently owned by institutional investors.

Shares of CVS Health Corporation (NYSE:CVS) traded down 1.05% during trading on Monday, reaching $89.17. The company had a trading volume of 7,479,197 shares. The firm has a market capitalization of $95.07 billion, a PE ratio of 20.51 and a beta of 0.84. The stock has a 50 day moving average price of $95.13 and a 200 day moving average price of $98.29. CVS Health Corporation has a 12 month low of $86.50 and a 12 month high of $106.67.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.02. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The firm earned $43.70 billion during the quarter, compared to analyst estimates of $44.28 billion. During the same period in the previous year, the company earned $1.19 EPS. The company’s revenue for the quarter was up 17.6% on a year-over-year basis. On average, equities research analysts forecast that CVS Health Corporation will post $5.86 EPS for the current year.

A number of equities research analysts recently commented on CVS shares. Mizuho increased their price objective on shares of CVS Health Corporation from $108.00 to $111.00 and gave the company a “buy” rating in a research note on Thursday, August 4th. Leerink Swann reissued a “buy” rating on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Credit Suisse Group AG reissued a “buy” rating and issued a $115.00 price objective on shares of CVS Health Corporation in a research note on Sunday, June 5th. Jefferies Group reissued a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 4th. Finally, Argus reissued a “buy” rating and issued a $120.00 price objective on shares of CVS Health Corporation in a research note on Thursday, August 4th. Six investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $113.02.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.